You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRL Exercise Disclosure
Andrews Nancy C · SEC Form 4 · Filed Aug 20, 2026
Exercise
Calculated transaction value
$0
Andrews Nancy C Director
Transaction date
Aug 18, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 2 days later
CRL daily price context
Close on/before transaction
$279.19
Aug 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (Right to Buy) on Common Stock
- Quantity / price
- 573 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001100682-26-000134
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$257.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Charles River Laboratories International, Inc. CRL Current | Exercise | Aug 18, 2026 | $0 |
| Charles River Laboratories International, Inc. CRL | Sale | Aug 18, 2026 | $163.44K |
| Charles River Laboratories International, Inc. CRL | Exercise | Aug 18, 2026 | $94.14K |